28406758|t|Fasting triglycerides as a predictor of incident diabetes, insulin resistance and β-cell function in a Canadian First Nation
28406758|a|Diabetes prevalence is substantially higher among Canadian First Nations populations than the non-First Nation population. Fasting serum triglycerides have been found to be an important predictor of incident diabetes among non-indigenous populations. However, there is a great need to understand diabetes progression within specific ethnic groups, particularly First Nations populations. The purpose of this study was to test for an association between fasting serum triglycerides and incident diabetes, changes in insulin resistance and changes in β-cell function in a Manitoba First Nation cohort. Study data were from two diabetes screening studies in Sandy Bay First Nation in Manitoba, Canada, collected in 2002/2003 and 2011/2012. The cohort was composed of respondents to both screening studies (n=171). Fasting blood samples and anthropometric, health and demographic data were collected. A generalised linear model with Poisson distribution was used to test for an association between fasting triglycerides and incident diabetes. There were 35 incident cases of diabetes among 128 persons without diabetes at baseline. Participants who developed incident type 2 diabetes were significantly older and had significantly higher body mass index (BMI; p=0.012), total cholesterol (p=0.007), fasting triglycerides (p<0.001), and Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) (p<0.001). Fasting triglyceride level was found to be a statistically significant positive predictor of incident diabetes independent of age, sex and waist circumference at baseline. Participants with triglycerides in the highest tertile (≥2.11 mmol/l) had a 4.0-times higher risk of developing incident diabetes compared to those in the lowest tertile (p=0.03). Notably, neither waist circumference nor BMI were significant predictors of incident diabetes independent of age, sex and triglycerides. Fasting triglycerides may be useful as a clinical predictor of insulin resistance and diabetes development among First Nations populations. Unlike other ethnic groups, BMI and waist circumference may be less important factors in diabetes development.
28406758	0	7	Fasting	T033	UMLS:C0015663
28406758	8	21	triglycerides	T103	UMLS:C0041004
28406758	49	57	diabetes	T038	UMLS:C0011847
28406758	59	77	insulin resistance	T038	UMLS:C0021655
28406758	82	97	β-cell function	T038	UMLS:C0007613
28406758	125	133	Diabetes	T038	UMLS:C0011847
28406758	219	246	non-First Nation population	T098	UMLS:C1257890
28406758	248	255	Fasting	T033	UMLS:C0015663
28406758	256	261	serum	T031	UMLS:C0229671
28406758	262	275	triglycerides	T103	UMLS:C0041004
28406758	333	341	diabetes	T038	UMLS:C0011847
28406758	348	374	non-indigenous populations	T098	UMLS:C1257890
28406758	421	429	diabetes	T038	UMLS:C0011847
28406758	430	441	progression	T038	UMLS:C0242656
28406758	458	471	ethnic groups	T098	UMLS:C0015031
28406758	533	538	study	T062	UMLS:C0681814
28406758	578	585	fasting	T033	UMLS:C0015663
28406758	586	591	serum	T031	UMLS:C0229671
28406758	592	605	triglycerides	T103	UMLS:C0041004
28406758	619	627	diabetes	T038	UMLS:C0011847
28406758	640	658	insulin resistance	T038	UMLS:C0021655
28406758	674	689	β-cell function	T038	UMLS:C0007613
28406758	695	703	Manitoba	T082	UMLS:C0024726
28406758	717	723	cohort	T098	UMLS:C0599755
28406758	750	758	diabetes	T038	UMLS:C0011847
28406758	759	776	screening studies	T062	UMLS:C2348164
28406758	780	802	Sandy Bay First Nation	T098	UMLS:C1257890
28406758	806	814	Manitoba	T082	UMLS:C0024726
28406758	816	822	Canada	T082	UMLS:C0006823
28406758	866	872	cohort	T098	UMLS:C0599755
28406758	889	900	respondents	T098	UMLS:C0282122
28406758	909	926	screening studies	T062	UMLS:C2348164
28406758	936	943	Fasting	T033	UMLS:C0015663
28406758	944	957	blood samples	T031	UMLS:C0178913
28406758	1024	1035	generalised	T082	UMLS:C0205246
28406758	1119	1126	fasting	T033	UMLS:C0015663
28406758	1127	1140	triglycerides	T103	UMLS:C0041004
28406758	1154	1162	diabetes	T038	UMLS:C0011847
28406758	1196	1204	diabetes	T038	UMLS:C0011847
28406758	1215	1222	persons	T098	UMLS:C0027361
28406758	1231	1239	diabetes	T038	UMLS:C0011847
28406758	1253	1265	Participants	T098	UMLS:C0679646
28406758	1289	1304	type 2 diabetes	T033	UMLS:C3280267
28406758	1310	1329	significantly older	T098	UMLS:C1518563
28406758	1359	1374	body mass index	T201	UMLS:C1305855
28406758	1376	1379	BMI	T201	UMLS:C1305855
28406758	1397	1408	cholesterol	T103	UMLS:C0008377
28406758	1420	1427	fasting	T033	UMLS:C0015663
28406758	1428	1441	triglycerides	T103	UMLS:C0041004
28406758	1457	1507	Homeostatic Model Assessment of Insulin Resistance	T058	UMLS:C3639411
28406758	1509	1516	HOMA-IR	T058	UMLS:C3639411
28406758	1529	1536	Fasting	T033	UMLS:C0015663
28406758	1537	1549	triglyceride	T103	UMLS:C0041004
28406758	1600	1608	positive	T033	UMLS:C1446409
28406758	1631	1639	diabetes	T038	UMLS:C0011847
28406758	1668	1687	waist circumference	T201	UMLS:C0455829
28406758	1701	1713	Participants	T098	UMLS:C0679646
28406758	1719	1732	triglycerides	T103	UMLS:C0041004
28406758	1822	1830	diabetes	T038	UMLS:C0011847
28406758	1898	1917	waist circumference	T201	UMLS:C0455829
28406758	1922	1925	BMI	T201	UMLS:C1305855
28406758	1966	1974	diabetes	T038	UMLS:C0011847
28406758	2003	2016	triglycerides	T103	UMLS:C0041004
28406758	2018	2025	Fasting	T033	UMLS:C0015663
28406758	2026	2039	triglycerides	T103	UMLS:C0041004
28406758	2081	2099	insulin resistance	T038	UMLS:C0021655
28406758	2104	2112	diabetes	T038	UMLS:C0011847
28406758	2171	2184	ethnic groups	T098	UMLS:C0015031
28406758	2186	2189	BMI	T201	UMLS:C1305855
28406758	2194	2213	waist circumference	T201	UMLS:C0455829
28406758	2247	2255	diabetes	T038	UMLS:C0011847